{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2018)
Source URL:
First approved in 2012
Source:
M020
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 355
(2012)
Source URL:
First approved in 2012
Source:
21 CFR 355
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Biocell by DeLaval Inc.
(2012)
Source URL:
First approved in 2012
Source:
Biocell by DeLaval Inc.
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2013)
Source URL:
First approved in 2012
Source:
21 CFR 347
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
OB Complete Chewable by Vertical Pharmaceuticals Inc.
(2012)
Source URL:
First approved in 2012
Source:
OB Complete Chewable by Vertical Pharmaceuticals Inc.
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M017
(2024)
Source URL:
First approved in 2012
Source:
21 CFR 358H
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
505G(a)(3)
(2012)
Source URL:
First approved in 2012
Source:
505G(a)(3)
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
Anbiser B-HA Hyaluronic Acid Nourishing by Qingdao Huinorde Biotechnology Co., LTD
(2024)
Source URL:
First approved in 2012
Source:
21 CFR 333D
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
BREAK FREE by mybody
(2012)
Source URL:
First approved in 2012
Source:
BREAK FREE by mybody
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2017)
Source URL:
First approved in 2012
Source:
Zithranol by Elorac Inc.
Source URL:
Class:
MIXTURE